Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 5/2007

01.10.2007 | Original Article

Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180

verfasst von: QuanHong Liu, XiaoBing Wang, Pan Wang, LiNa Xiao, Qiao Hao

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The comparison between sonodynamic antitumor effect with protoporphyrin IX (PPIX) and hematoporphyrin (Hp) at a concentration of 5 mg/kg on Sarcoma 180 (S180) cells was studied in vivo, and the potential cell damage mechanism was also investigated.

Methods

The sonodynamically induced anti-tumor effect of PPIX was studied in mice bearing S180 solid tumors. In order to determine the optimum timing of ultrasound exposure after administration of PPIX, the PPIX concentrations in plasma, skin, muscle and tumor were determined by the fluorescence intensity of tissue extractions with a fluorescence spectrophotometer based on the standard curve. Anti-tumor effects were estimated by measuring the tumor size and the tumor weight. Additionally, the morphological changes of S180 cells were evaluated by transmission electron microscope (TEM) observation immediately after sonodynamic therapy (SDT) treatment.

Results

A time of 24 h after the intravenous administration of PPIX was chosen as the best time for ultrasound exposure. The antitumor effect induced by PPIX mediated sonodynamic therapy (PPIX-SDT) was in a dose dependent manner when ultrasound intensity was at or above the inertial cavitation threshold (5 W/cm2). A significant tumor growth delay was observed both in PPIX mediated sonodynamic therapy and in Hp mediated sonodynamic therapy treatments (Hp-SDT), and the tumor weight inhibition ratios after the synergistic treatments were 42.82 ± 0.03 and 35.22 ± 0.03%, respectively, this difference was significant at P < 0.05. While ultrasound alone (5 W/cm2) showed a slight tumor growth inhibitory effect compared with the control group, and PPIX or Hp alone showed almost no significant effect. Furthermore, TEM observation indicated cell damage was more serious in PPIX-SDT treatment group than in Hp-SDT treatment group. After sonication, the cell ultra-structure such as cell membrane destruction, mitochondria swelling, chromatin condensation might be important factors that inhibited the tumor growth and even induced cell death.

Conclusions

The comparative results suggested that PPIX as a sonosensitizer might have more potential cytotoxicity than Hp when irradiated with ultrasound, and the ultra-structural changes may account for cell destruction induced by sonodynamic therapy in our experiment mode.
Literatur
1.
Zurück zum Zitat Umemura S, Yumita N, Nishifaki R, Umemura K (1989) Sonochemical activation of hematoporphyrin: a potential modality for cancer treatment. IEEE Ultrason Symp 9:955CrossRef Umemura S, Yumita N, Nishifaki R, Umemura K (1989) Sonochemical activation of hematoporphyrin: a potential modality for cancer treatment. IEEE Ultrason Symp 9:955CrossRef
2.
Zurück zum Zitat Tachibana K, Kimura N, Okumura M, Eguchi H, Tachibana S (1993) Enhancement of cell killing of HL-60 cells by ultrasound in the presence of the photosensitizing drug Photofrin II. Cancer Lett 72:195PubMedCrossRef Tachibana K, Kimura N, Okumura M, Eguchi H, Tachibana S (1993) Enhancement of cell killing of HL-60 cells by ultrasound in the presence of the photosensitizing drug Photofrin II. Cancer Lett 72:195PubMedCrossRef
3.
Zurück zum Zitat Kessel D, Jeffers R, Fowlkes JB, Cain C (1994) Porphyrin-induced enhancement of ultrasound cytotoxicity. Int J Radiat Biol 66:221PubMedCrossRef Kessel D, Jeffers R, Fowlkes JB, Cain C (1994) Porphyrin-induced enhancement of ultrasound cytotoxicity. Int J Radiat Biol 66:221PubMedCrossRef
4.
Zurück zum Zitat Kondo T, Umemura S, Tanabe K, Ogawa R, Adachi I, Riesz P (2000) Novel therapeutic applications of ultrasound: utilization of thermal and cavitational effects. Jpn J Hyperthermic Oncol 16:203 Kondo T, Umemura S, Tanabe K, Ogawa R, Adachi I, Riesz P (2000) Novel therapeutic applications of ultrasound: utilization of thermal and cavitational effects. Jpn J Hyperthermic Oncol 16:203
5.
Zurück zum Zitat Feril LB, Kondo T, Umemura S, Tachibana K, Manalo AH, Riesz P (2002) Sound waves and antineoplastic drugs: the possibility of an enhanced combined anticancer therapy. J Med Ultrason 29:173CrossRef Feril LB, Kondo T, Umemura S, Tachibana K, Manalo AH, Riesz P (2002) Sound waves and antineoplastic drugs: the possibility of an enhanced combined anticancer therapy. J Med Ultrason 29:173CrossRef
6.
Zurück zum Zitat Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R (1997) Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B 40:313PubMedCrossRef Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R (1997) Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B 40:313PubMedCrossRef
7.
Zurück zum Zitat Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275PubMedCrossRef Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275PubMedCrossRef
8.
Zurück zum Zitat Sharwani A, Jerjes W, Salih V, MacRobert AJ, El-Maaytah M, Khalil HS, Hopper C (2006) Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B 83:27PubMedCrossRef Sharwani A, Jerjes W, Salih V, MacRobert AJ, El-Maaytah M, Khalil HS, Hopper C (2006) Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B 83:27PubMedCrossRef
9.
Zurück zum Zitat Abels C, FritschC, Bolsen K, Szeimies RM, Ruzicka T, Goerz G, Goetz AE (1997) Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo. J Photochem Photobiol B 40:76PubMedCrossRef Abels C, FritschC, Bolsen K, Szeimies RM, Ruzicka T, Goerz G, Goetz AE (1997) Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo. J Photochem Photobiol B 40:76PubMedCrossRef
10.
Zurück zum Zitat Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H (1998) Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 68:218PubMedCrossRef Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H (1998) Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 68:218PubMedCrossRef
11.
Zurück zum Zitat Bartosova J, Hrkal Z (2000) Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA). Comp Biochem Physiol C Toxicol Pharmacol 126:245PubMed Bartosova J, Hrkal Z (2000) Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA). Comp Biochem Physiol C Toxicol Pharmacol 126:245PubMed
12.
Zurück zum Zitat Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006) Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B 84:213PubMedCrossRef Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006) Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B 84:213PubMedCrossRef
13.
Zurück zum Zitat Lee CF, Lee CJ, Chen CT, Huang CT (2004) delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. J Photochem Photobiol B 75:21PubMedCrossRef Lee CF, Lee CJ, Chen CT, Huang CT (2004) delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. J Photochem Photobiol B 75:21PubMedCrossRef
14.
Zurück zum Zitat Schuitmaker JJ, Baas P, Leengoed HL, Meulen FW, Star WM, Zandwijk N (1996) Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol B 34:3PubMedCrossRef Schuitmaker JJ, Baas P, Leengoed HL, Meulen FW, Star WM, Zandwijk N (1996) Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol B 34:3PubMedCrossRef
15.
Zurück zum Zitat Andreas Dietze, Kristian Berg (2005) ALA-induced porphyrin formation and fluorescence in synovitis tissue in vitro and in vivo studies. Photodiagn Photodyn Ther 4(2):299 Andreas Dietze, Kristian Berg (2005) ALA-induced porphyrin formation and fluorescence in synovitis tissue in vitro and in vivo studies. Photodiagn Photodyn Ther 4(2):299
16.
Zurück zum Zitat Peng Q, Moan J, Warloe T, Nesland JM, Rimington C (1992) Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 52:433PubMedCrossRef Peng Q, Moan J, Warloe T, Nesland JM, Rimington C (1992) Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 52:433PubMedCrossRef
17.
Zurück zum Zitat Klinteberg C AF, Enejder AM, Wang I, Andersson-Engels S, Svanberg S, Svanberg K (1999) Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. J Photochem Photobiol B 49:120CrossRef Klinteberg C AF, Enejder AM, Wang I, Andersson-Engels S, Svanberg S, Svanberg K (1999) Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. J Photochem Photobiol B 49:120CrossRef
18.
Zurück zum Zitat Orenstein A, Kostenich G, Malik Z (1997) The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors. Cancer Lett 120:229PubMedCrossRef Orenstein A, Kostenich G, Malik Z (1997) The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors. Cancer Lett 120:229PubMedCrossRef
19.
Zurück zum Zitat Kinoshita M, Hynynen K (2006) Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia. Radiat Res 165:299PubMedCrossRef Kinoshita M, Hynynen K (2006) Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia. Radiat Res 165:299PubMedCrossRef
20.
Zurück zum Zitat Liu QH, Wang XB, Wang P, Qi H, Zhang K, Xiao LN (2006) Sonodynamic effects of protoporphyrin IX disodium salt on isolated sarcoma 180 cells. Ultrasonics 45:56PubMedCrossRef Liu QH, Wang XB, Wang P, Qi H, Zhang K, Xiao LN (2006) Sonodynamic effects of protoporphyrin IX disodium salt on isolated sarcoma 180 cells. Ultrasonics 45:56PubMedCrossRef
21.
Zurück zum Zitat Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R (1996) Recent advances in sonodynamic approach to cancer therapy. Ultra Sonochem 3(3):187CrossRef Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R (1996) Recent advances in sonodynamic approach to cancer therapy. Ultra Sonochem 3(3):187CrossRef
22.
Zurück zum Zitat Liu QH, Sun SH, Xiao YP, Qi H, Shang ZY, Zhang J P, Zhang JX, Ren YH, Li M, Li Q(2003a) Study of cell killing on S180 by different intensity ultrasound activate hematoporphyrin derivatives. Sci China Ser C 46(3):253 Liu QH, Sun SH, Xiao YP, Qi H, Shang ZY, Zhang J P, Zhang JX, Ren YH, Li M, Li Q(2003a) Study of cell killing on S180 by different intensity ultrasound activate hematoporphyrin derivatives. Sci China Ser C 46(3):253
23.
Zurück zum Zitat Meng JW, Wang XJ, Lin T, Ren XG, Pang HF, Zhou CN (1999) The study of protoporphyrin IX metabolism in cell proliferation using photoluminescence method. J Lumin 83–84:271CrossRef Meng JW, Wang XJ, Lin T, Ren XG, Pang HF, Zhou CN (1999) The study of protoporphyrin IX metabolism in cell proliferation using photoluminescence method. J Lumin 83–84:271CrossRef
24.
Zurück zum Zitat Yumita N, Nishigaki R, Umemura S (2000a) Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma. J Cancer Res Clin Oncol 126(10):601CrossRef Yumita N, Nishigaki R, Umemura S (2000a) Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma. J Cancer Res Clin Oncol 126(10):601CrossRef
25.
Zurück zum Zitat Yumita N, Umemura S (2003) Sonodynamic therapy with photofrin II on AH130 solid tumor. Cancer Chemother Pharmacol 51(2):174PubMed Yumita N, Umemura S (2003) Sonodynamic therapy with photofrin II on AH130 solid tumor. Cancer Chemother Pharmacol 51(2):174PubMed
26.
Zurück zum Zitat Yumita N, Umemura S (2004) Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour. J Pharm Pharmacol 56:85PubMedCrossRef Yumita N, Umemura S (2004) Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour. J Pharm Pharmacol 56:85PubMedCrossRef
27.
Zurück zum Zitat Dougherty TJ (1993) Photodynamic therapy. Photochem Photobiol 58(6):895PubMed Dougherty TJ (1993) Photodynamic therapy. Photochem Photobiol 58(6):895PubMed
28.
Zurück zum Zitat Kessel D (1986) Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett 33(2):183PubMedCrossRef Kessel D (1986) Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett 33(2):183PubMedCrossRef
29.
Zurück zum Zitat Tang W, Liu QH, Liu SY (2005) Determination of HpD distribution in tumor bearing mouse with fluorescence photometer. J Northwest Univ (Nat Sci Edn) 35:436 Tang W, Liu QH, Liu SY (2005) Determination of HpD distribution in tumor bearing mouse with fluorescence photometer. J Northwest Univ (Nat Sci Edn) 35:436
30.
Zurück zum Zitat Doan N, Reher P, Meghji S, Harris M (1999) In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes. J Oral Maxillofac Surg 57:409PubMedCrossRef Doan N, Reher P, Meghji S, Harris M (1999) In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes. J Oral Maxillofac Surg 57:409PubMedCrossRef
31.
Zurück zum Zitat Liu QH, Wang P, Li M, Qi H, Shang ZY, Ren YH, Zhang K, Yao X (2003) Apopotosis of Ehrl ich ascites tumor cells by sonochemical-activated hematoporphyrin. Acta Zoologica Sinica 49:620 Liu QH, Wang P, Li M, Qi H, Shang ZY, Ren YH, Zhang K, Yao X (2003) Apopotosis of Ehrl ich ascites tumor cells by sonochemical-activated hematoporphyrin. Acta Zoologica Sinica 49:620
32.
Zurück zum Zitat Liu QH, Sun SH, Xiao YP, Qi H, Zhang JX, Ren YH, Wang P (2004) Synergistic anti-tumor effect of ultrasound and hematoporphyrin on sarcoma180 cells with special reference to the changes of morphology and cytochrome oxidase activity of tumor cells. J Exp Clin Cancer Res 23(2):333 Liu QH, Sun SH, Xiao YP, Qi H, Zhang JX, Ren YH, Wang P (2004) Synergistic anti-tumor effect of ultrasound and hematoporphyrin on sarcoma180 cells with special reference to the changes of morphology and cytochrome oxidase activity of tumor cells. J Exp Clin Cancer Res 23(2):333
33.
Zurück zum Zitat Yu T, Wang Z, Mason TJ (2004) A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11(2):95PubMedCrossRef Yu T, Wang Z, Mason TJ (2004) A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11(2):95PubMedCrossRef
34.
Zurück zum Zitat Rosenthal I, Sostaric JZ, Riesz (2004) Sonodynamic therapy—a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11(6):349PubMed Rosenthal I, Sostaric JZ, Riesz (2004) Sonodynamic therapy—a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11(6):349PubMed
35.
Zurück zum Zitat Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S (2000) Sonodynamically induced antitumor effect of 4-formyloximeethylidene-3-hydroxy-2-vinyl-deuterio-porphynyl(IX) -6–7-diaspartic acid (ATX-S10). Jpn J Cancer Res 91(2):255PubMed Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S (2000) Sonodynamically induced antitumor effect of 4-formyloximeethylidene-3-hydroxy-2-vinyl-deuterio-porphynyl(IX) -6–7-diaspartic acid (ATX-S10). Jpn J Cancer Res 91(2):255PubMed
36.
Zurück zum Zitat Ogawa K, Tachibana K, Uchida T, Tai T, Yamashita N, Tsujita N, Miyauchi R (2001) High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med Electron Microsc 34:249PubMedCrossRef Ogawa K, Tachibana K, Uchida T, Tai T, Yamashita N, Tsujita N, Miyauchi R (2001) High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med Electron Microsc 34:249PubMedCrossRef
37.
Zurück zum Zitat Briviba K, Klotz LO, Sies H (1997) Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems. Biol Chem 378:1259PubMed Briviba K, Klotz LO, Sies H (1997) Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems. Biol Chem 378:1259PubMed
38.
Zurück zum Zitat Umemura S, Yumita N, Umemura K, Nishigaki R (1999) Sonodynamically induced effect of rose bengal on isolated sarcoma 180 cells. Cancer Chemother Pharmacol 43:389PubMedCrossRef Umemura S, Yumita N, Umemura K, Nishigaki R (1999) Sonodynamically induced effect of rose bengal on isolated sarcoma 180 cells. Cancer Chemother Pharmacol 43:389PubMedCrossRef
39.
Zurück zum Zitat Xu YM, Zhang Y, Yang YZ (1995) Character of photosensitive damage of PP, Hp and DHE to the structure of main-chain of protein. Chin J Light Scatter 7:163 Xu YM, Zhang Y, Yang YZ (1995) Character of photosensitive damage of PP, Hp and DHE to the structure of main-chain of protein. Chin J Light Scatter 7:163
40.
Zurück zum Zitat Liu QH, Liu SY, Qi H, Wang P, Tang W, Zhang K, Dai L, Shi YC (2005) Preliminary study on the mechanism of apoptosis in Ehrl ich ascites tumor cells by sonochemical activated hematoporphyrin. Acta Zoologica Sinica 51:1073 Liu QH, Liu SY, Qi H, Wang P, Tang W, Zhang K, Dai L, Shi YC (2005) Preliminary study on the mechanism of apoptosis in Ehrl ich ascites tumor cells by sonochemical activated hematoporphyrin. Acta Zoologica Sinica 51:1073
Metadaten
Titel
Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180
verfasst von
QuanHong Liu
XiaoBing Wang
Pan Wang
LiNa Xiao
Qiao Hao
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 5/2007
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-006-0413-4

Weitere Artikel der Ausgabe 5/2007

Cancer Chemotherapy and Pharmacology 5/2007 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.